
Kentasu Raises ¥84 Million Seed to Automate Insurance Claims for Southeast Asia's Clinics and Hospitals
Tokyo healthtech startup Kentasu Inc. has raised ¥84 million in a seed round announced on 20 November 2026, subscribed by Nissei Capital (ニッセイ・キャピタル) — the venture capital firm of Japan's Nippon Life group — the Tokyo Wellness Impact Fund, operated by Capital Medica Ventures, and individual investors (company announcement; PR TIMES release). The capital will move the company's AI platform, Kentasu RCM, into full-scale deployment in Malaysia from 2027 — clinics first, then hospitals, then other Southeast Asian markets. The round is also a case study in explaining a complex product to the people who sign.
📣 The opportunity on the table: Kentasu now has to explain claims automation clinic by clinic across Malaysia — a reminder that a funded idea still has to be understood by the people who sign. Jason Lim's Future of Selling — Presentation Skills Coaching Program publishes its own track record for you to check on the page (20+ years teaching and coaching presentation skills, and $20M+ in verified deals across 42 cities — the program's own published claims). The path runs from the Beginners' Class through the 12-week Signature to private 1:1 coaching, by application, with a free consultation and WhatsApp booking. Next step: apply for the free consultation while the window is early.
What Kentasu RCM Actually Does
Per the release, Kentasu RCM works from information in electronic medical records, with AI automating claims to each insurer's rules and submission methods, and unifies claims across insurers through to deposit and collection management (our translation from Japanese). The release states that at pilot and adopting facilities, staff hours on targeted claims work have fallen by up to 90% (company-reported result), and that the core technology is under a PCT international patent application. Kentasu's English site adds that the clinic product works alongside the clinic management system a clinic already uses, that production data stays on servers in Malaysia, and that data handling is PDPA-compliant and never used to train AI.
Inside the Round
Nissei Capital, founded in 1991 within the Nippon Life group, states in the release that it has invested in more than 1,000 ventures to date (our translation). The Tokyo Wellness Impact Fund is described there as an impact fund specialising in wellness, established through the Tokyo Metropolitan Government's social-impact investment fund programme — a fact about the fund's founding, not a government endorsement of Kentasu. A senior capitalist at Nissei Capital credits Sato's decade-plus in Asian healthcare and the team built with co-founder Yosuke Kimoto; the fund's director points to the social weight of easing providers' revenue-management burden (both comments as translated; investor personal names are omitted from this article).
Why Malaysia First — and Why Now
Kentasu's Malaysian subsidiary, Kentasu Sdn. Bhd. (Reg. No. 202601041603), was set up in Kuala Lumpur in October 2026 (kentasu.my news). From 2027, the release states, introduction begins at scale centred on Malaysian clinics, extends to hospitals, and aims eventually at expansion across Southeast Asia. Three uses of funds are named there: advancing the AI claims feature and expanding supported insurers; building sales and customer-success teams in Malaysia; and strengthening information security. The release cites Mercer Marsh Benefits' Health Trends 2026 projecting a 2026 medical-cost trend of 12.5% on average across Asia, 15.0% in Malaysia and 17.8% in Indonesia (as cited by the release; we have not read the report), and Market.us projecting 24.2% annual growth for the global AI-enabled RCM market (as cited). It also notes that insurers' management of medical costs is tightening — pressure that raises the value of cleaner claims work. BlueAura, a Malaysian vendor, also operates in the related healthcare-AI automation space.
The Founders Behind the Bet
CEO Hajime Sato graduated in economics from Hitotsubashi University, has worked from a Southeast Asia base since 2012 on hospital management and medical IT, founded Kentasu in 2024, and completed the US AAPC "Revenue Cycle Manager" credential (release profile). Kentasu's English site describes him as having "over 15 years establishing and operating hospitals in Asia, and building and investing in healthcare IT businesses", and quotes his mission: "Building and running hospitals in Southeast Asia taught us one thing: healthcare providers can only deliver good care when they are financially healthy. Kentasu exists to make that possible." In the release (our translation), he aims for "a mechanism that delivers money to healthcare providers correctly and quickly", starting with claims and growing into infrastructure connecting healthcare and finance. Co-founder and CTO Yosuke Kimoto began at Fujitsu on the K computer and co-founded BuzzElement in Malaysia, leading it as CTO through its 2017 exit (kentasu.my).
Related News
- What Are Coaching Classes and Are They the Best Way to Build Your Speaking Skills? — from our FAQ library on building speaking skills.
- Is tech sales worth it? — from our FAQ library on sales careers.
- Future of Selling — Presentation Skills Coaching Program — the program page, including the P.I.T.C.H. method and program levels.
Ad — DreamakerAI, an AI CRM and business OS by DreaMaker Ventures (Jason Lim's venture studio): one place to run follow-up, pipeline and customer records while you build the pitch that fills them. Explore it at dreamaker.club/ai.
🎯 Results, one step at a time: the P.I.T.C.H. method (Power, Intent, Teach, Close, Habits) taught in Jason Lim's program is described on the program's own page as "the exact steps that turn a presentation into a signed deal" — from commanding the room to a follow-up habit that compounds. Advantage+ clients have their actual pitch reviewed and rebuilt with them; Beginners' Class students build a "Leak Map" of where their leads stall. Book the free consultation by application and see which of the five steps to work on first.
What It Means for Singapore, China and Asia
The following is editorial analysis, not company statement. First, study the Malaysia-first wedge: Kentasu launched where the operating pain is sharpest, not where the venture money is densest, and the release describes Southeast Asia's RCM digitisation as still developing — founders in Singapore and China can test whether their sharpest wedge market is really their most obvious one. Second, treat market variation as a question, not a given: the cited cost trends differ widely — 12.5% Asia average, 15.0% Malaysia, 17.8% Indonesia — and insurer rules and regulatory structures differ with them, so ask how a claims product localises market by market before reading any regional rollout as linear. Third, ask what data your product accumulates: the release states claims and payment data will become the base for payments and early financing for medical institutions, under the banner of "Asia's medical-finance infrastructure" — the same question applies to any founder's roadmap.
Three Speaking Lessons Hiding in This Story
Analysis, offered conditionally — every team and room differs.
1. Put the number where the buyer's money sits. Before: "Kentasu RCM is an AI-powered revenue cycle management platform for Southeast Asian healthcare." After: "Your team stops retyping the same claim into one payer portal after another — and more of your cash arrives on time." The first sentence describes the vendor; the second describes the buyer's Tuesday.
2. Rehearse the sixty-second version a clinic owner could repeat. Built only from the stated facts: "Every insurer you bill has its own rules, submission method and portal, so your staff retype claims system after system. Kentasu RCM brings claims to all your insurers into one place and manages them through to payment and collection. At pilot and adopting facilities, targeted claims work took up to 90% less staff time. Would it help to see how it fits the clinic management system you already use?" Sixty seconds, one number, one next step.
3. After a pilot yes, run a written follow-up checklist. A pilot agreement is not a rollout. Send a one-paragraph recap the same day: what was agreed, who does what, by when. Name the person on each side and a date for the first review. Agree one success measure in the buyer's words — for claims software, hours spent per week on claims. If silence runs past that date, follow up once, in writing, with the recap attached. Ghosting can sometimes mean the next step was never made concrete; treat silence as information about the approval process, not automatically a verdict on your product.
An Opportunity Window for Singapore and Asia's Startups
Here is a number to sit with. In NACE's (National Association of Colleges and Employers) data, reported by Kevin Gray for NACE on 13 January 2025, new graduates rated their own communication proficiency at 78.1% while employers rated it at 53.5% — drawn from NACE's 2024 Student Survey (20,482 students) and Job Outlook 2025 (237 employers). The figure concerns new graduates' communication skills generally — not Kentasu or any specific company — but the pattern travels: we tend to overestimate how clearly we come across, and the people deciding our deals see the gap.
The transformation worth building toward is walking out of rooms with decisions instead of maybes. Jason Lim's Future of Selling — Presentation Skills Coaching Program teaches the five-step P.I.T.C.H. method, with your actual pitch reviewed and rebuilt in the 1:1 Advantage+ tier — free consultation by application, WhatsApp booking, from the Beginners' Class through the 12-week Signature. The window is open: apply for your free consult today, and work toward leaving your next room with a decision — results vary by person and effort.
